Related Experiment Video

Updated: May 22, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

Nanovector delivery of siRNA for cancer therapy

H Shen1, T Sun, M Ferrari

  • 1The Methodist Hospital Research Institute, Houston, TX, USA.

Cancer Gene Therapy
|May 5, 2012
PubMed

Insights

Small interfering RNA (siRNA) offers potential for cancer gene knockdown. Nanotechnology-based delivery systems are crucial for overcoming in vivo challenges and achieving tumor-specific targeting of siRNA therapeutics.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • RNA interference (RNAi) using small interfering RNA (siRNA) presents a promising strategy for targeting cancer genes.
  • Significant investment has been made in developing siRNA therapeutics, yet effective in vivo delivery remains a major obstacle.
  • Nanotechnology plays a vital role in creating delivery vectors for siRNA cancer treatments.

Purpose of the Study:

  • To review current nanovectors used for siRNA delivery in cancer therapy.
  • To discuss the technical challenges associated with overcoming biological barriers for effective siRNA delivery.
  • To introduce a novel multistage vector system designed for tumor-specific delivery of siRNA.

Main Methods:

  • Review of existing literature on nanovectors for siRNA delivery.
  • Analysis of biological barriers impacting in vivo siRNA efficacy.
  • Description of a multistage vector system for targeted cancer therapy.

Main Results:

  • Nanotechnology has advanced siRNA delivery vector development.
  • Biological barriers present significant challenges to effective in vivo siRNA therapy.
  • A multistage vector system shows potential for tumor-specific siRNA delivery.

Conclusions:

  • Effective in vivo delivery of siRNA therapeutics is critical for cancer treatment.
  • Nanotechnology offers solutions for overcoming delivery hurdles.
  • Multistage vector systems represent a promising approach for targeted cancer gene silencing.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...